Charles Snead - Vasamed Director
| VSMD Stock | USD 0.0001 0.00 0.00% |
Director
Charles D. Snead, Jr. was Director of Optical Sensors since June 2000. Mr. Snead is an attorney and has served in various legal, executive, and board of director positions in several New York and Nasdaq stock exchange listed companies over a period of 30 years since 2000.
| Age | 77 |
| Tenure | 24 years |
| Phone | 952-944-5857 |
| Web | https://www.vasamed.com |
Vasamed Management Efficiency
The company has return on total asset (ROA) of (0.741) % which means that it has lost $0.741 on every $100 spent on assets. This is way below average. Vasamed's management efficiency ratios could be used to measure how well Vasamed manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| JeanMarc Raby | SCOR PK | 59 | |
| Augustin Romanet | SCOR PK | 55 | |
| Gerard Andreck | SCOR PK | 71 | |
| Guylaine Saucier | SCOR PK | 68 | |
| Michele Aronvald | SCOR PK | 57 | |
| Wang Zhen | SCOR PK | 61 | |
| Thierry Derez | SCOR PK | 60 | |
| Thomas Saunier | SCOR PK | 51 | |
| Kevin Knoer | SCOR PK | 58 | |
| Daniel Valot | SCOR PK | 70 | |
| Bruno Pfister | SCOR PK | 59 | |
| Peter Eckert | SCOR PK | 70 | |
| Jane WickerMiurin | SCOR PK | 59 | |
| Vincent Foucart | SCOR PK | 39 | |
| Guillaume Sarkozy | SCOR PK | 64 | |
| Augustin Beaune | SCOR PK | 57 | |
| Vanessa Marquette | SCOR PK | 46 | |
| Kory Sorenson | SCOR PK | 49 | |
| Charles Gave | SCOR PK | 71 | |
| Claude Tendil | SCOR PK | 72 | |
| Andreas Brandstetter | SCOR PK | 45 | |
Management Performance
| Return On Asset | -0.74 |
Vasamed Leadership Team
Elected by the shareholders, the Vasamed's board of directors comprises two types of representatives: Vasamed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vasamed. The board's role is to monitor Vasamed's management team and ensure that shareholders' interests are well served. Vasamed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vasamed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Terry Duesterhoeft, Vice President of Sales and Marketing | ||
| Andrew Jay, Director | ||
| Michael Schreiber, Pres CEO | ||
| Roberta Dircks, CFO and VP of Fin. and Admin. | ||
| Wesley Peterson, Sec | ||
| Daniel Bartnik, CTO Operations | ||
| Paulita LaPlante, CEO and President and Director | ||
| Charles Snead, Director | ||
| Kent Winger, VP of Operations and VP of Strategic Planning and Product Devel. | ||
| Richard Egen, Director | ||
| Craig Walker, Director |
Vasamed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Vasamed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.74 | |||
| Profit Margin | (0.56) % | |||
| Operating Margin | (0.47) % | |||
| Current Valuation | 2.89 M | |||
| Shares Owned By Institutions | 0.30 % | |||
| Price To Earning | (0.33) X | |||
| Price To Sales | 0.84 X | |||
| Revenue | 3.13 M | |||
| Gross Profit | 1.73 M | |||
| EBITDA | (1.47 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vasamed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vasamed's short interest history, or implied volatility extrapolated from Vasamed options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vasamed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Vasamed Pink Sheet analysis
When running Vasamed's price analysis, check to measure Vasamed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vasamed is operating at the current time. Most of Vasamed's value examination focuses on studying past and present price action to predict the probability of Vasamed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vasamed's price. Additionally, you may evaluate how the addition of Vasamed to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |